Mark C. Lanasa, MD, PhD
Department / Division
Medicine /
Medicine - Hematological Malignancies
Address
DUMC 3872
Durham, NC 27710
Appointment Telephone
919-684-8964
Office Telephone
919-684-8964
Fax Telephone
919-684-5325
- MD, University of Pittsburgh School of Medicine (Pennsylvania), 2002
- Internal Medicine, Duke University Medical Center, 2002-2005
- Hematology-Medical Oncology, Duke University Medical Center, 2005-2008
- PhD, Biochemistry and Molecular Genetics, University of Pittsburgh (Pennsylvania), 2000
Clinical Interests
Chronic lymphocytic leukemia, small lymphocytic lymphoma, B-cell lymphoproliferative disorders
Research Interests
Chronic Lymphocytic Leukemia, B Cell Lymphoproliferative Disorders
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Genentech, Inc (Roche Holding)
- Hospira, Inc.
Representative Publications
Lanasa, MC; Allgood, SD; Slager, SL; Dave, SS; Love, C; Marti, GE; Kay, NE; Hanson, CA; Rabe, KG; Achenbach, SJ; Goldin, LR; Camp, NJ; Goodman, BK; Vachon, CM; Spector, LG; Rassenti, LZ; Leis, JF; Gockerman, JP; Strom, SS; Call, TG; Glenn, M; Cerhan, JR; Levesque, MC; Weinberg, JB; Caporaso, NE. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia. 2011;25:1459-1466.
(2011)
Abstract
Lanasa, MC; Weinberg, JB. Immunoglobulin class switch recombination in chronic lymphocytic leukemia. Leukemia and Lymphoma. 2011;52:1398-1400.
(2011)
Abstract
Lanasa, MC; Weinberg, JB. Immunologic aspects of monoclonal B-cell lymphocytosis. Immunologic Research: a selective reference to current research and practice. 2011;49:269-280.
(2011)
Abstract
Slager, SL; Rabe, KG; Achenbach, SJ; Vachon, CM; Goldin, LR; Strom, SS; Lanasa, MC; Spector, LG; Rassenti, LZ; Leis, JF; Camp, NJ; Glenn, M; Kay, NE; Cunningham, JM; Hanson, CA; Marti, GE; Weinberg, JB; Morrison, VA; Link, BK; Call, TG; Caporaso, NE; Cerhan, JR. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2011;117:1911-1916.
(2011)
Abstract
Goldin, LR; Lanasa, MC; Slager, SL; Cerhan, JR; Vachon, CM; Strom, SS; Camp, NJ; Spector, LG; Leis, JF; Morrison, VA; Glenn, M; Rabe, KG; Achenbach, SJ; Algood, SD; Abbasi, F; Fontaine, L; Yau, M; Rassenti, LZ; Kay, NE; Call, TG; Hanson, CA; Weinberg, JB; Marti, GE; Caporaso, NE. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. British Journal of Haematology. 2010;151:152-158.
(2010)
Abstract
Lanasa, MC. Novel insights into the biology of CLL. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2010;2010:70-76.
(2010)
Abstract
Lanasa, MC; Allgood, SD; Volkheimer, AD; Gockerman, JP; Whitesides, JF; Goodman, BK; Moore, JO; Weinberg, JB; Levesque, MC. Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia. 2010;24:133-140.
(2010)
Abstract
Rawstron, AC; Shanafelt, T; Lanasa, MC; Landgren, O; Hanson, C; Orfao, A; Hillmen, P; Ghia, P. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry Part B: Clinical Cytometry. 2010;78 Suppl 1:S19-S23.
(2010)
Abstract
Shanafelt, TD; Ghia, P; Lanasa, MC; Landgren, O; Rawstron, AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512-520.
(2010)
Abstract
Slager, SL; Goldin, LR; Strom, SS; Lanasa, MC; Spector, LG; Rassenti, L; Leis, JF; Camp, NJ; Kay, NE; Vachon, CM; Glenn, M; Weinberg, JB; Rabe, KG; Cunningham, JM; Achenbach, SJ; Hanson, CA; Marti, GE; Call, TG; Caporaso, NE; Cerhan, JR. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiology, Biomarkers and Prevention. 2010;19:1098-1102.
(2010)
Abstract
Lanasa, MC; Allgood, SD; Bond, KM; Gockerman, JP; Levesque, MC; Weinberg, JB. Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL. British Journal of Haematology. 2009;145:535-537.
(2009)
Abstract
Weinberg, JB; Volkheimer, AD; Chen, Y; Beasley, BE; Jiang, N; Lanasa, MC; Friedman, D; Vaccaro, G; Rehder, CW; Decastro, CM; Rizzieri, DA; Diehl, LF; Gockerman, JP; Moore, JO; Goodman, BK; Levesque, MC. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. American Journal of Hematology. 2007;82:1063-1070.
(2007)
Abstract
